Exposure of melanoma cells to MGCM resulted in upregulated levels of IL-6 secreted from M12.CB3 and M16.CB3 cells, compared to the basal levels of secreted IL-6 from naïve (control) melanoma cells (Figure 4f). This evidence concerns the gene IL6 and melanoma.